Gayarre Javier, Stamatakis Konstantinos, Renedo Marta, Pérez-Sala Dolores
Departamento de Estructura y Función de Proteínas, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu, Madrid, Spain.
FEBS Lett. 2005 Oct 24;579(25):5803-8. doi: 10.1016/j.febslet.2005.09.069. Epub 2005 Oct 6.
Cyclopentenone prostaglandins (cyPG) with antiinflammatory and antiproliferative properties have been envisaged as leads for the development of therapeutic agents. Because cyPG effects are mediated in part by the formation of covalent adducts with critical signaling proteins, it is important to assess the specificity of this interaction. By using biotinylated derivatives of 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)-B) and PGA(1) (PGA(1)-B) we herein provide novel evidence for the differential selectivity of protein modification by distinct cyPG. The marked quantitative and qualitative differences in the binding of 15d-PGJ(2)-B and PGA(1)-B to cellular proteins were related to a differential reactivity in the presence of glutathione (GSH), both in vitro and in intact cells. Therefore GSH levels may influence not only the intensity but also the specificity of cyPG action.
具有抗炎和抗增殖特性的环戊烯酮前列腺素(cyPG)被视为治疗药物开发的先导物。由于cyPG的作用部分是通过与关键信号蛋白形成共价加合物来介导的,因此评估这种相互作用的特异性很重要。通过使用15-脱氧-Δ(12,14)-前列腺素J2(15d-PGJ(2)-B)和PGA(1)(PGA(1)-B)的生物素化衍生物,我们在此提供了新的证据,证明不同的cyPG对蛋白质修饰具有不同的选择性。15d-PGJ(2)-B和PGA(1)-B与细胞蛋白结合的显著定量和定性差异与谷胱甘肽(GSH)存在下的不同反应性有关,无论是在体外还是在完整细胞中。因此,GSH水平不仅可能影响cyPG作用的强度,还可能影响其特异性。